Literature DB >> 17710672

Pro-MMP-9 is associated with poor prognosis in gastric cancer.

Yukihiro Nomura1, Kunika Takasaki, Masakazu Tada, Masataka Yoshimoto, Hideyuki Ishida, Nobuo Murata, Shunichiro Kubota.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17710672     DOI： 10.1080/00365520701435881

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN： 0036-5521            Impact factor:   2.423


× No keyword cloud information.
  4 in total

1.  Overexpression of SPAG9 in human gastric cancer is correlated with poor prognosis.

Authors:  Zhi-Feng Miao; Zhen-Ning Wang; Ting-Ting Zhao; Ying-Ying Xu; Jian-Hua Wu; Xing-Yu Liu; Hao Xu; Yi You; Hui-Mian Xu
Journal:  Virchows Arch       Date:  2015-08-21       Impact factor: 4.064

2.  Overexpression of dihydrodiol dehydrogenase as a prognostic marker in resected gastric cancer patients.

Authors:  Hung-Chi Chang; Yao-Li Chen; Chien-Pin Chan; Kun-Tu Yeh; Shou-Jen Kuo; Chih-Jan Ko; Hsin-Yuan Fang
Journal:  Dig Dis Sci       Date:  2008-07-05       Impact factor: 3.199

Review 3.  Nanoparticles in Gastrooncology.

Authors:  André Jefremow; Markus F Neurath
Journal:  Visc Med       Date:  2020-03-18

4.  Intelligently targeted drug delivery and enhanced antitumor effect by gelatinase-responsive nanoparticles.

Authors:  Rutian Li; Wei Wu; Qin Liu; Puyuan Wu; Li Xie; Zhenshu Zhu; Mi Yang; Xiaoping Qian; Yin Ding; Lixia Yu; Xiqun Jiang; Wenxian Guan; Baorui Liu
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.